Expand Coverage and Improve the Quality of Facility and Community-Based PMTCT Support for Rollout of Option B+ Services in the Littoral and Center Regions of Cameroon under PEPFAR. | CDC RFA GH15 150802CONT16

Opportunity Information: Apply for CDC RFA GH15 150802CONT16

The grant opportunity titled "Expand Coverage and Improve the Quality of Facility and Community-Based PMTCT Support for Rollout of Option B+ Services in the Littoral and Center Regions of Cameroon under PEPFAR" is a U.S. Centers for Disease Control and Prevention (CDC) funding action under PEPFAR that focuses on strengthening prevention of mother-to-child transmission (PMTCT) of HIV services in two key regions of Cameroon: Littoral and Center. In practical terms, it is aimed at helping health facilities and community programs improve how they identify HIV-positive pregnant and breastfeeding women, initiate them on lifelong antiretroviral therapy under Option B+ (a policy approach where all pregnant and breastfeeding women living with HIV start treatment and remain on treatment for life), and keep mothers and infants engaged in care through pregnancy, delivery, postpartum follow-up, and infant HIV testing.

This specific notice is categorized as continuation funding, meaning it is not a new, open competition for first-time applicants. The description makes clear that the funds are intended only for organizations that were already awarded under the earlier funding opportunity announcement (FOA) CDC-RFA-GH15-1508. The opportunity number, CDC RFA GH15 150802CONT16, signals it is a continuation action linked to that original award. Because it is continuation funding, the purpose is typically to allow an existing, active project to keep operating and to build on progress already made, rather than launching a brand-new project with a new implementing partner.

The mechanism is a cooperative agreement, which usually means the CDC expects to have substantial involvement in the work beyond simply providing funds. In cooperative agreements, the recipient carries out program activities, but CDC often plays an active role through technical assistance, program oversight, monitoring and evaluation support, and collaboration on work planning and performance targets. The activity category is health, and the CFDA (Catalog of Federal Domestic Assistance) number listed is 93.067, which aligns with CDC global HIV-related assistance programming.

Although the brief listing does not spell out detailed work components, the title and program focus point to a combination of facility-based and community-based interventions designed to expand coverage (reaching more eligible women, infants, and families) and improve quality (making services more effective, consistent, and patient-centered). Facility-based support in PMTCT commonly involves strengthening antenatal care and maternity services to ensure routine HIV testing and counseling, rapid linkage to treatment, consistent clinical follow-up, reliable antiretroviral availability, integration with maternal and child health services, and stronger documentation of the PMTCT cascade. Community-based support typically focuses on demand creation, adherence counseling, defaulter tracing, peer or mentor mother support models, stigma reduction, partner engagement, and improving retention for women who might otherwise be lost to follow-up during or after pregnancy. For Option B+ specifically, quality improvement often emphasizes same-day initiation where appropriate, sustained adherence, viral load monitoring where available, and long-term continuity of care after delivery.

The geographic focus on the Littoral and Center regions is significant because these areas include major urban and peri-urban populations (including Douala in Littoral and Yaounde in Center), where there can be both high service volume and persistent gaps in consistent PMTCT coverage, retention, and follow-up. Work in these settings often requires coordination across large referral hospitals, district facilities, and community networks, with an emphasis on standardizing practices across sites and ensuring that mothers and infants can move through the care system without dropping out.

From the source data, several administrative details stand out. The original closing date shown is October 23, 2015, which reflects the timeline associated with the original or related announcement rather than an open, current solicitation for new applications. The award ceiling is listed as 0, which commonly appears in continuation records or listings where a public maximum is not stated, where funding is determined by previously approved budgets, or where the listing is informational rather than competitive. The record also notes "Eligible Applicants: Others," but because it is continuation funding specifically restricted to prior awardees under FOA CDC-RFA-GH15-1508, eligibility is effectively limited to those organizations already holding that award. The expected number of awards is not provided in the excerpt, which is also typical for continuation actions that may be tied to a single existing recipient or a limited set of prior recipients.

Overall, this opportunity is best understood as a CDC/PEPFAR continuation cooperative agreement designed to sustain and deepen an ongoing PMTCT/Option B+ rollout effort in Cameroon, with a strong emphasis on improving both reach and service quality at health facilities while reinforcing community systems that support retention, adherence, and follow-up for mothers and HIV-exposed infants.

• The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Expand Coverage and Improve the Quality of Facility and Community-Based PMTCT Support for Rollout of Option B+ Services in the Littoral and Center Regions of Cameroon under PEPFAR." and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
• This funding opportunity was created on 2015-09-17.
• Applicants must submit their applications by 2015-10-23. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Eligible applicants include: Others.

Apply for CDC RFA GH15 150802CONT16

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: